Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 76 results.
User Information
Export Records
  1. 1.   Biased antagonism of CXCR4 avoids antagonist tolerance
  2. Hitchinson, Ben; Eby, Jonathan M.; Gao, Xianlong; Guite-Vinet, Francois; Ziarek, Joshua J.; Abdelkarim, Hazem; Lee, Youngshim; Okamoto, Yukari; Shikano, Sojin; Majetschak, Matthias; Heveker, Nikolaus; Volkman, Brian F.; Tarasova,Nadya; Gaponenko, Vadim
  3. Science signaling. 2018, Oct 16; 11(552):
  1. 2.   HIV-1 Capsid-Targeting Domain of Cleavage and Polyadenylation Specificity Factor 6
  2. Lee, K.; Mulky, A.; Yuen, W.; Martin, T. D.; Meyerson, N. R.; Choi, L.; Yu, H.; Sawyer, S. L.; KewalRamani, V. N.
  3. Journal of Virology. 2012, Apr; 86(7): 3851-3860.
  1. 3.   Effect of single post-ovulatory administration of levonorgestrel on gene expression profile during the receptive period of the human endometrium
  2. Vargas, M. F.; Tapia-Pizarro, A. A.; Henriquez, S. P.; Quezada, M.; Salvatierra, A. M.; Noe, G.; Munroe, D. J.; Velasquez, L. A.; Croxatto, H. B.
  3. Journal of Molecular Endocrinology. 2012, Feb; 48(1): 25-36.
  1. 4.   Hypoxia, stem cells and bone tumor
  2. Zeng, W.; Wan, R.; Zheng, Y. H.; Singh, S. R.; Wei, Y. Y.
  3. Cancer Letters. 2011, Dec; 313(2): 129-136.
  1. 5.   Development of thyroid gland and ultimobranchial body cyst is independent of p63
  2. Ozaki, T.; Nagashima, K.; Kusakabe, T.; Kakudo, K.; Kimura, S.
  3. Laboratory Investigation. 2011, Jan; 91(1): 138-146.
  1. 6.   Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
  2. Stockwin, L. H.; Yu, S. X.; Borgel, S.; Hancock, C.; Wolfe, T. L.; Phillips, L. R.; Hollingshead, M. G.; Newton, D. L.
  3. International Journal of Cancer. 2010, Dec; 127(11): 2510-2519.
  1. 7.   Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L)
  2. Mayeenuddin, L. H.; Yu, Y.; Kang, Z.; Helman, L. J.; Cao, L.
  3. Oncogene. 2010, Dec; 29(48): 6367-6377.
  1. 8.   A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
  2. Lindstrom, S.; Ma, J.; Altshuler, D.; Giovannucci, E.; Riboli, E.; Albanes, D.; Allen, N. E.; Berndt, S. I.; Boeing, H.; Bueno-de-Mesquita, H. B.; Chanock, S. J.; Dunning, A. M.; Feigelson, H. S.; Gaziano, J. M.; Haiman, C. A.; Hayes, R. B.; Henderson, B. E.; Hunter, D. J.; Kaaks, R.; Kolonel, L. N.; Le Marchand, L.; Martinez, C.; Overvad, K.; Siddiq, A.; Stampfer, M.; Stattin, P.; Stram, D. O.; Thun, M. J.; Trichopoulos, D.; Tumino, R.; Virtamo, J.; Weinstein, S. J.; Yeager, M.; Kraft, P.; Freedman, M. L.
  3. Journal of Clinical Endocrinology & Metabolism. 2010, Sep; 95(9): E121-E127.
  1. 9.   Sleeping Beauty-Mediated Somatic Mutagenesis Implicates CSF1 in the Formation of High-Grade Astrocytomas
  2. Bender, A. M.; Collier, L. S.; Rodriguez, F. J.; Tieu, C.; Larson, J. D.; Halder, C.; Mahlum, E.; Kollmeyer, T. M.; Akagi, K.; Sarkar, G.; Largaespada, D. A.; Jenkins, R. B.
  3. Cancer Research. 2010, May; 70(9): 3557-3565.
  1. 10.   PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
  2. Dossus, L.; Kaaks, R.; Canzian, F.; Albanes, D.; Berndt, S. I.; Boeing, H.; Buring, J.; Chanock, S. J.; Clavel-Chapelon, F.; Feigelson, H. S.; Gaziano, J. M.; Giovannucci, E.; Gonzalez, C.; Haiman, C. A.; Hallmans, G.; Hankinson, S. E.; Hayes, R. B.; Henderson, B. E.; Hoover, R. N.; Hunter, D. J.; Khaw, K. T.; Kolonel, L. N.; Kraft, P.; Ma, J.; Le Marchand, L.; Lund, E.; Peeters, P. H. M.; Stampfer, M.; Stram, D. O.; Thomas, G.; Thun, M. J.; Tjonnel, A.; Trichopoulos, D.; Tumino, R.; Riboli, E.; Virtamo, J.; Weinstein, S. J.; Yeager, M.; Ziegler, R. G.; Cox, D. G.
  3. Carcinogenesis. 2010, Mar; 31(3): 455-461.
  1. 11.   Flexible Use of Nuclear Import Pathways by HIV-1
  2. Lee, K.; Ambrose, Z.; Martin, T. D.; Oztop, I.; Mulky, A.; Julias, J. G.; Vandegraaff, N.; Baumann, J. G.; Wang, R.; Yuen, W.; Takemura, T.; Shelton, K.; Taniuchi, I.; Li, Y.; Sodroski, J.; Littman, D. R.; Coffin, J. M.; Hughes, S. H.; Unutmaz, D.; Engelman, A.; KewalRamani, V. N.
  3. Cell Host & Microbe. 2010, Mar; 7(3): 221-233.
  1. 12.   Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads
  2. Rapisarda, A.; Shoemaker, R. H.; Melillo, G.
  3. Cell Cycle. 2009, Dec; 8(24): 4040-4043.
  1. 13.   Effect of Tumor Necrosis Factor-alpha on Estrogen Metabolism and Endometrial Cells: Potential Physiological and Pathological Relevance
  2. Salama, S. A.; Kamel, M. W.; Diaz-Arrastia, C. R.; Xu, X.; Veenstra, T. D.; Salih, S.; Botting, S. K.; Kumar, R.
  3. Journal of Clinical Endocrinology & Metabolism. 2009 94(1): 285-293.
  1. 14.   C/EBP beta regulates body composition, energy balance-related hormones and tumor growth
  2. Staiger, J.; Lueben, M. J.; Berrigan, D.; Malik, R.; Perkins, S. N.; Hursting, S. D.; Johnson, P. F.
  3. Carcinogenesis. 2009 30(5): 832-840.
  1. 15.   Monoclonal antibodies against components of the IGF system for cancer treatment
  2. Feng, Y.; Dimitrov, D. S.
  3. Current Opinion in Drug Discovery & Development. 2008 11(2): 178-185.
  1. 16.   Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones
  2. Nunez, N. P.; Perkins, S. N.; Smith, N.; Berrigan, D.; Berendes, D. M.; Varticovski, L.; Barrett, J. C.; Hursting, S. D.
  3. Nutrition and Cancer-an International Journal. 2008 60(4): 534-541.
  1. 17.   CAATT/enhancer-binding proteins alpha and delta interact with NKX2-1 to synergistically activate mouse secretoglobin 3A2 gene expression
  2. Tomita, T.; Kido, T.; Kurotani, R.; Iemura, S. I.; Sterneck, E.; Natsume, T.; Vinson, C.; Kimura, S.
  3. Journal of Biological Chemistry. 2008 283(37): 25617-25627.
  1. 18.   DNA palindromes with a modest arm length of greater than or similar to s20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart in mice
  2. Inagaki, K.; Lewis, S. M.; Wu, X. L.; Ma, C. R.; Munroe, D. J.; Fuess, S.; Storm, T. A.; Kay, M. A.; Nakai, H.
  3. Journal of Virology. 2007, Oct; 81(20): 11290-11303.
  1. 19.   Enzymatic digestion of the milk protein beta-casein releases potent chemotactic peptide(s) for monocytes and macrophages
  2. Kitazawa, H.; Yonezawa, K.; Tohno, M.; Shimosato, T.; Kawai, Y.; Saito, T.; Wang, J. M.
  3. International Immunopharmacology. 2007, Sep; 7(9): 1150-1159.
  1. 20.   Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival
  2. Bian, X. W.; Yang, S. X.; Chen, L. H.; Ping, Y. F.; Zhou, X. D.; Wang, Q. L.; Jiang, X. F.; Gong, W. H.; Xiao, H. L.; Du, L. L.; Chen, Z. Q.; Zhao, W.; Shi, L. Q.; Wang, J. M.
  3. Neurosurgery. 2007, Sep; 61(3): 570-578.
  1. 21.   Grb10 and active Raf-1 kinase promote bad-dependent cell survival
  2. Kebache, S.; Ash, J.; Annis, M. G.; Hagan, J.; Huber, M.; Hassard, J.; Stewart, C. L.; Whiteway, M.; Nantel, A.
  3. Journal of Biological Chemistry. 2007, Jul; 282(30): 21873-21883.
  1. 22.   Targeting hypoxia cell signaling for cancer therapy
  2. Melillo, G.
  3. Cancer and Metastasis Reviews. 2007, Jun; 26(2): 341-352.
  1. 23.   Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): Novel marker for cervical carcinogenesis
  2. Miyatake, T.; Ueda, Y.; Nakashima, R.; Yoshino, K.; Kimura, T.; Murata, T.; Nomura, T.; Fujita, M.; Buzard, G. S.; Enomoto, T.
  3. International Journal of Cancer. 2007, May; 120(10): 2068-2077.
  1. 24.   Cellular and tissue distribution of intravenously administered agalsidase alfa
  2. Murray, G. J.; Anver, M. R.; Kennedy, M. A.; Quirk, J. M.; Schiffmann, R.
  3. Molecular Genetics and Metabolism. 2007, Mar; 90(3): 307-312.
  1. 25.   Hypoxia-inducible factor 1 inhibitors
  2. Melillo, G.
  3. Oxygen Biology and Hypoxia. 2007; 435 : 385-402.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel